2-Furancarboxylic acid, 5-formyl-, 1,1-dimethylethyl ester | 889858-13-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 呋喃
• 英文名称: 2-Furancarboxylic acid, 5-formyl-, 1,1-dimethylethyl ester
• 英文别名: tert-butyl 5-formylfuran-2-carboxylate
• CAS: 889858-13-3
• 化学式: C₁₀H₁₂O₄
• 分子量: 196.203
• InChiKey: VCVKNAIUPXSZGX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  14
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  56.5
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-Furancarboxylic acid, 5-formyl-, 1,1-dimethylethyl ester 在 (1S,2R)-2-(二丁氨基)-1-苯基-1-丙醇 、 一水合肼 、 三苯基膦 、 偶氮二甲酸二乙酯 作用下， 以 四氢呋喃 、 甲醇 、 乙醇 、 正己烷 、 乙酸乙酯 、 甲苯 为溶剂， 反应 19.5h， 生成 tert-butyl 5-[(1R)-1-aminopropyl]-2-furancarboxylate D-tartrate
  参考文献：
  名称：

  Discovery of novel series of 6-benzyl substituted 4-aminocarbonyl-1,4-diazepane-2,5-diones as human chymase inhibitors using structure-based drug design

  摘要：

  A novel series of 6-benzyl substituted 4-aminocarbonyl-1,4-diazepane-2,5-diones were explored as human chymase inhibitors using structure-based drug design according to the X-ray cocrystal structure of chymase and compound 1. The optimization focused on the prime site led to the attainment of compounds that showed potent inhibitory activity, and among them, 18R shows a novel interaction mode. (C) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2013.04.079
• 作为产物：
  描述：

  5-甲醛基呋喃-2-羧酸 、 O-tert-butyl-N,N-diisopropyl-isourea 以 二氯甲烷 为溶剂， 反应 12.0h， 以10.97 g的产率得到2-Furancarboxylic acid, 5-formyl-, 1,1-dimethylethyl ester
  参考文献：
  名称：

  Discovery of novel series of 6-benzyl substituted 4-aminocarbonyl-1,4-diazepane-2,5-diones as human chymase inhibitors using structure-based drug design

  摘要：

  A novel series of 6-benzyl substituted 4-aminocarbonyl-1,4-diazepane-2,5-diones were explored as human chymase inhibitors using structure-based drug design according to the X-ray cocrystal structure of chymase and compound 1. The optimization focused on the prime site led to the attainment of compounds that showed potent inhibitory activity, and among them, 18R shows a novel interaction mode. (C) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2013.04.079

文献信息

• [EN] AMINE OR (THIO)AMIDE CONTAINING LXR MODULATORS<br/>[FR] MODULATEURS DE LXR À BASE D'AMINE OU DE (THIO) AMIDE
  申请人：PHENEX FXR GMBH

  公开号：WO2019016269A1

  公开（公告）日：2019-01-24

  The present invention relates to derivatives of formula (I) which bind to the liver X receptor (LXRα and/or LXRβ) and act preferably as inverse agonists of LXR.

  本发明涉及公式（I）的衍生物，其结合到肝X受体（LXRα和/或LXRβ），并且作为LXR的拮抗剂。
• 7-MEMBERED RING COMPOUND AND METHOD OF PRODUCTION AND PHARMACEUTICAL APPLICATION THEREOF
  申请人：Muto Tsuyoshi

  公开号：US20090253683A1

  公开（公告）日：2009-10-08

  A 7-membered heterocyclic compound having the formula (I), or its salt, or a solvate thereof with a chymase inhibitory action and useful for the prevention or treatment of various diseases, in which chymase is involved: a method for producing the same, and a pharmaceutical composition useful for the prevention or treatment of diseases, in which chymase is involved, including the compound of having the formula (I), or its pharmaceutically acceptable salt, or a solvate thereof are provided.

  本发明提供一种具有式(I)的7元杂环化合物或其盐或其溶剂合物，具有抑制chymase的作用，用于预防或治疗各种涉及chymase的疾病的方法，以及用于预防或治疗各种涉及chymase的疾病的药物组合物，包括具有式(I)的化合物或其药学上可接受的盐或其溶剂合物的药物组合物。
• 7-membered ring compound and method of production and pharmaceutical application thereof
  申请人：Muto Tsuyoshi

  公开号：US20090111796A1

  公开（公告）日：2009-04-30

  A 7-membered heterocyclic compound having the formula (I), or its salt, or a solvate thereof with a chymase inhibitory action and useful for the prevention or treatment of various diseases, in which chymase is involved: a method for producing the same, and a pharmaceutical composition useful for the prevention or treatment of diseases, in which chymase is involved, including the compound of having the formula (I), or its pharmaceutically acceptable salt, or a solvate thereof are provided.

  提供了一种具有以下公式（I）或其盐或溶剂化物的七元杂环化合物，具有抑制chymase作用，可用于预防或治疗各种涉及chymase的疾病的方法，以及用于预防或治疗这些疾病的制药组合物，包括具有以下公式（I）或其药学上可接受的盐或溶剂化物的化合物。
• SEVEN-MEMBERED RING COMPOUND, PRODUCTION METHOD THEREOF AND PHARMACEUTICAL USE THEREOF
  申请人：Asubio Pharma Co., Ltd.

  公开号：EP2025672A1

  公开（公告）日：2009-02-18

  A 7-membered heterocyclic compound having the formula (I), or its salt, or a solvate thereof with a chymase inhibitory action and useful for the prevention or treatment of various diseases, in which chymase is involved: a method for producing the same, and a pharmaceutical composition useful for the prevention or treatment of diseases, in which chymase is involved, including the compound of having the formula (I), or its pharmaceutically acceptable salt, or a solvate thereof are provided.

  本发明提供了一种具有式 (I) 的 7 元杂环化合物，或其盐，或其溶液，具有糜蛋白酶抑制作用，可用于预防或治疗涉及糜蛋白酶的各种疾病：一种生产该化合物的方法，以及一种用于预防或治疗涉及糜蛋白酶的疾病的药物组合物，包括具有式 (I) 的化合物，或其药学上可接受的盐，或其溶液。
• Aminomethyl-substituted aromatic acids as intermediates for the preparation of chymase inhibiting 1,4-diazepan-2,5-dione compounds
  申请人：Daiichi Sankyo Company, Limited

  公开号：EP2463268A1

  公开（公告）日：2012-06-13

  A compound, or its salt or a solvate thereof, having the formula (Va): for producing a 7-membered heterocyclic compound, or its salt or a solvate thereof having formula (I): the compound of formula (I) having a chymase inhibitory action and useful for the prevention or treatment of various diseases in which chymase is involved and a method of producing a compound of formula (I) from a compound of formula (Va) are provided.

  具有式 (Va) 的化合物或其盐或溶液： 用于生产式（I）的 7 元杂环化合物或其盐或其溶液： 本发明提供了具有糜蛋白酶抑制作用并可用于预防或治疗涉及糜蛋白酶的各种疾病的式 (I) 化合物，以及由式 (Va) 化合物生产式 (I) 化合物的方法。